6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Heart and soul: heart rate variability and major depression.

      1 ,
      Behavioural pharmacology
      Ovid Technologies (Wolters Kluwer Health)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There is a bidirectional relationship between affective disorders and cardiovascular abnormalities, often described as a downward spiral, whereas major depressive disorders (MDD, and anxiety disorders) significantly increase the risk of developing cardiovascular diseases (CVD); CVD are also associated with increased risk of developing MDD (and anxiety disorders). Moreover, the prognosis and progression of CVD is significantly worsened in the presence of MDD. Heart rate variability (HRV) has often been suggested as a potential mediator in this comorbidity. In this review, we discuss HRV alterations in MDD. However, we mainly focus on the direct relationship between HRV alterations and psychiatric symptoms, rather than its relationship with CVD, as this has been reviewed elsewhere. After a general introduction to HRV and how it can be measured, we review how HRV is altered in MDD. We subsequently describe how antidepressant drugs affect HRV, showing that some classes (such as tricyclics) generally worsen HRV, whereas others (most notably selective serotonin reuptake inhibitors) have a more positive influence. We also review the effects of several other treatments, with a special focus on vagal nerve stimulation, finishing with some further considerations and recommendation for further research, both in humans and animals.

          Related collections

          Author and article information

          Journal
          Behav Pharmacol
          Behavioural pharmacology
          Ovid Technologies (Wolters Kluwer Health)
          1473-5849
          0955-8810
          Apr 2018
          : 29
          : 2 and 3 - Special Issue
          Affiliations
          [1 ] Victoria University of Wellington, Behavioural Neurogenetics Group, Wellington, New Zealand.
          Article
          00008877-201804000-00006
          10.1097/FBP.0000000000000387
          29543649
          a45108f6-99e3-459a-a2d5-6f21513dac0a
          History

          Comments

          Comment on this article